The LancetVolume 398, Issue 10304, 11–17 September 2021, Pages 1015-1020ViewpointWhat are the obligations of pharmaceutical companies in a global health emergency?Author links open overlay panelEzekiel J Emanuel MD a, Allen Buchanan PhD c, Shuk Ying Chan PhD d, Cécile Fabre PhD e, Daniel Halliday PhD g, Joseph Heath PhD h, Lisa Herzog DPhil i, R J Leland PhD j, Matthew S McCoy PhD a, Ole F Norheim MD k, Carla Saenz PhD l, G Owen Schaefer DPhil m, Kok-Chor Tan PhD b, Christopher Heath Wellman PhD n, Jonathan Wolff MPhil f, Govind Persad PhD oShow moreShareCitehttps://doi.org/10.1016/S0140-6736(21)01378-7Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2021 Elsevier Ltd. All rights reserved.